Dr. Mary-Alice Abbott, MD

NPI: 1982799417
Total Payments
$41,871
2024 Payments
$750.00
Companies
2
Transactions
80

Payment Breakdown by Category

Consulting$25,349 (60.5%)
Research$5,229 (12.5%)
Travel$4,949 (11.8%)
Other$4,266 (10.2%)
Food & Beverage$2,078 (5.0%)
Education$0.78 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,349 9 60.5%
Unspecified $5,229 10 12.5%
Travel and Lodging $4,949 20 11.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,266 7 10.2%
Food and Beverage $2,078 33 5.0%
Education $0.78 1 0.0%

Payments by Type

General
$36,642
70 transactions
Research
$5,229
10 transactions

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $41,870 79 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $750.00 2 GENZYME CORPORATION ($750.00)
2023 $1,250 3 GENZYME CORPORATION ($1,250)
2022 $3,576 3 GENZYME CORPORATION ($3,576)
2021 $4,510 2 GENZYME CORPORATION ($4,510)
2020 $8,304 13 GENZYME CORPORATION ($8,304)
2019 $8,958 17 GENZYME CORPORATION ($8,958)
2018 $11,124 27 GENZYME CORPORATION ($11,124)
2017 $3,398 13 GENZYME CORPORATION ($3,398)

All Payment Transactions

80 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
02/07/2024 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $500.00 Research
Study: Pompe Disease Registry • Category: Genetic Disease
01/31/2024 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $250.00 Research
Study: Pompe Registry • Category: Genetic Disease
11/01/2023 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $250.00 Research
Study: Pompe Registry • Category: Genetic Disease
07/03/2023 GENZYME CORPORATION NEXVIAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $500.00 General
Category: Genetic Disease
02/24/2023 GENZYME CORPORATION LUMIZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $500.00 General
Category: Genetic Disease
09/30/2022 GENZYME CORPORATION LUMIZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $500.00 General
Category: Genetic Disease
09/30/2022 GENZYME CORPORATION LUMIZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $250.00 General
Category: Genetic Disease
09/29/2022 GENZYME CORPORATION LUMIZYME (Biological) Consulting Fee Cash or cash equivalent $2,826.00 General
Category: Genetic Disease
09/28/2021 GENZYME CORPORATION LUMIZYME (Biological) Consulting Fee Cash or cash equivalent $1,732.00 General
Category: Genetic Disease
02/09/2021 GENZYME CORPORATION Consulting Fee Cash or cash equivalent $2,778.00 General
06/30/2020 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $480.00 Research
Study: Pompe Registry • Category: Genetic Disease
03/31/2020 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $940.00 Research
Study: Pompe Registry • Category: Genetic Disease
03/31/2020 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $390.00 Research
Study: Pompe Registry • Category: Genetic Disease
03/31/2020 GENZYME CORPORATION LUMIZYME (Biological) In-kind items and services $361.53 Research
Study: Pompe Registry • Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Consulting Fee Cash or cash equivalent $5,250.00 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Travel and Lodging In-kind items and services $371.28 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Travel and Lodging In-kind items and services $270.07 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Food and Beverage In-kind items and services $100.00 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Food and Beverage In-kind items and services $45.15 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Food and Beverage In-kind items and services $36.77 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Food and Beverage Cash or cash equivalent $22.22 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Travel and Lodging Cash or cash equivalent $20.26 General
Category: Genetic Disease
01/31/2020 GENZYME CORPORATION LUMIZYME (Biological) Travel and Lodging Cash or cash equivalent $17.14 General
Category: Genetic Disease
09/30/2019 GENZYME CORPORATION LUMIZYME (Drug) In-kind items and services $1,148.57 Research
Study: Pompe Registry • Category: RARE DISEASE GENETICS
09/30/2019 GENZYME CORPORATION LUMIZYME (Drug) In-kind items and services $454.29 Research
Study: Pompe Registry • Category: RARE DISEASE GENETICS

Research Studies & Clinical Trials

Study Name Company Amount Records
Pompe Registry GENZYME CORPORATION $4,729 9
Pompe Disease Registry GENZYME CORPORATION $500.00 1

About Dr. Mary-Alice Abbott, MD

Dr. Mary-Alice Abbott, MD is a Pediatrics healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982799417.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary-Alice Abbott, MD has received a total of $41,871 in payments from pharmaceutical and medical device companies, with $750.00 received in 2024. These payments were reported across 80 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($25,349).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Clinical Genetics (M.D.)
  • Location Worcester, MA
  • Active Since 10/03/2006
  • Last Updated 02/05/2025
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1982799417

Products in Payments

  • LUMIZYME (Biological) $15,112
  • LUMIZYME (Drug) $10,254
  • NO PRODUCT DISCUSSED (Drug) $9,828
  • MYOZYME (Drug) $3,398
  • NEXVIAZYME (Biological) $500.00
  • (820) Cholbam (Drug) $0.78

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Worcester